Contact information
Rosie Bradley
BSc, MSc
Medical Statistician
Rosie is a Medical Statistician in the Clinical Trial Service Unit (CTSU). Prior to joining in 2012, she studied Applied Statistics at the University of Plymouth (BSc) and Biometry at the University of Reading (MSc). She is currently involved in randomised trials in neurodegenerative diseases and is working on meta-analyses of breast cancer trials in EBCTCG.
Recent publications
-
Aromatase inhibitors versus tamoxifen in premenopausal women with oestrogen receptor-positive early-stage breast cancer treated with ovarian suppression: patient level meta-analysis of 7,030 women in four randomised trials
Journal article
BRADLEY R. et al, (2021), The Lancet Oncology
-
Trastuzumab for early-stage, HER2-positive breast cancer: a meta-analysis of 13 864 women in seven randomised trials.
Journal article
Early Breast Cancer Trialists’ Collaborative group (EBCTCG) None., (2021), Lancet Oncol, 22, 1139 - 1150
-
Assistive technology and telecare to maintain independent living at home for people with dementia: the ATTILA RCT.
Journal article
Gathercole R. et al, (2021), Health Technol Assess, 25, 1 - 156
-
The impact of assistive technology on burden and psychological well-being in informal caregivers of people with dementia (ATTILA Study).
Journal article
Davies A. et al, (2020), Alzheimers Dement (N Y), 6
-
Minocycline at 2 Different Dosages vs Placebo for Patients With Mild Alzheimer Disease: A Randomized Clinical Trial.
Journal article
Howard R. et al, (2019), JAMA Neurol